Arvinas, Inc. (ARVN) vs Crescent Biopharma, Inc. (CBIO)
A side-by-side comparison of Arvinas, Inc. and Crescent Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARVN
Arvinas, Inc.
$7.32HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
CBIO
Crescent Biopharma, Inc.
$14.18HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
Total return — ARVN vs CBIO
growth of $100 · dividends reinvested · last 8yARVN -53.5% (-9.1%/yr)CBIO -96.6% (-34.5%/yr)ARVN compounded faster over this window
Log scale — wide-divergence pair
ARVN CBIO
ARVN vs CBIO: by the numbers
- •CBIO is the larger company ($527M vs $472M market cap).
- •ARVN is profitable (2.94% net margin) while CBIO runs a net loss (-1371.51%).
- •ARVN grew revenue faster over the past five years (72.38% vs 39.89% CAGR).
Metrics side by side
Valuation
| Metric | ARVN | CBIO |
|---|---|---|
| P/E ratio | 45.74 | N/A |
| P/S ratio | 1.49 | 44.32 |
| P/B ratio | 0.84 | 3.31 |
Profitability
| Metric | ARVN | CBIO |
|---|---|---|
| Gross margin | 96.43% | 100.00% |
| Operating margin | -43.75% | -1407.52% |
| Net margin | 2.94% | -1371.51% |
| ROE | 1.65% | -99.83% |
| ROIC | -2.19% | -102.59% |
Growth (annualized)
| Metric | ARVN | CBIO |
|---|---|---|
| Revenue CAGR (5Y) | 72.38% | 39.89% |
| Total return CAGR (5Y) | -38.16% | -24.40% |
Frequently asked
- Which has grown faster, ARVN or CBIO?
- Over the past five years, ARVN grew revenue faster — ARVN at a 72.38% CAGR versus CBIO at 39.89%.
- Is ARVN or CBIO more profitable?
- ARVN runs the higher net margin — ARVN at 2.94% versus CBIO at -1371.51%.
- How have ARVN and CBIO total returns compared?
- Over the past 5 years, ARVN delivered -38.16% and CBIO delivered -24.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arvinas P/E ratioArvinas ROECrescent Biopharma ROEArvinas operating marginCrescent Biopharma operating marginArvinas revenue growthCrescent Biopharma revenue growthArvinas free cash flowCrescent Biopharma free cash flow
Arvinas & Crescent Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.